CHD1 and prostate cancer: Interestingly, in PTEN-deficient prostate cancer, the inactivation of CHD1 dramatically reduces proliferation and survival, due to its regulatory role on the tumor necrosis factor/nuclear factor kappa-light-chain-enhancer of activated B cells pathway [137].